The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
AHRMM Podcast on how supply chain should be interdepartmentally conversing to determine the handling of human-origin medical products and their UDIs.
Webcast
In this three-part series, Lisa Tonkinson and Chris Wiekert discuss how the Revenue Cycle can impact your supply chain when embarking on a new soft
Webcast
Continuing from Part 1, this short session updates supply chain professionals on the design and timing of the new small bore tubing connectors maki
On-Demand Educational Webinars
This webinar provides an overview of the reasons for drug shortages, recent advocacy efforts to ameliorate the situation, and action steps…
Podcasts
Hear one provider’s ongoing process of UDI implementation, from deciphering acronyms and educating interdepartmental staff, to working with vendors
Podcasts
In this three-part podcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship